Pregnant Women

HIV can be transmitted through bodily fluids such as blood, breast milk, semen, and vaginal secretions. Pregnant women who are infected with HIV should receive antiretroviral therapy (ART) as soon as possible to protect their own health and reduce the risk of transmitting HIV to their unborn child. At the recent 19th European AIDS Conference (EACS 2023), Professor Chen Yaokai and his team from the Chongqing Public Health Medical Treatment Center presented a report titled "The Effectiveness of Raltegravir in Virological Suppression of HIV-Positive Pregnant Women at Delivery: A Systematic Review and Meta-Analysis." The study analyzed the effectiveness of Raltegravir treatment for pregnant women with HIV, initiated at different stages of pregnancy, in achieving virological suppression at the time of delivery, and conducted subgroup analyses for treated and untreated pregnant women.